Department of Chemistry
Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors
Old dogs, new tricks! We applied structure-based virtual screening methods to identify small-molecule inhibitors of tumor necrosis factor-α (TNF-α) from a database of 3000 US Food and Drug Administration (FDA)-approved drugs. Darifenacin (Enablex) and ezetimibe (Zetia) were identified as direct TNF-α inhibition, representing only the fifth and sixth examples of small-molecule TNF-α inhibitors. © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Approved drugs, Drug discovery, Inhibitors, Tumor necrosis factor, Virtual screening
Source Publication Title
Link to Publisher's Edition
Leung, C., Chan, D., Kwan, M., Cheng, Z., Wong, C., Zhu, G., Fong, W., & Ma, D. (2011). Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors. ChemMedChem, 6 (5), 765-768. https://doi.org/10.1002/cmdc.201100016